Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation

Sang Yeop Kim; Jukyung Kang; Maria V. Fawaz; Minzhi Yu; Ziyun Xia; Emily E. Morin; Ling Mei; Karl Olsen; Xiang An Li; Anna Schwendeman

doi:10.2217/nnm-2023-0222

Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation

Sang Yeop Kim
, Jukyung Kang
, Maria V. Fawaz
, Minzhi Yu
, Ziyun Xia
, Emily E. Morin
, Ling Mei
, Karl Olsen
, Xiang An Li
, Anna Schwendeman

Producción científica: Article › revisión exhaustiva

7 Citas (Scopus)

Resumen

Aim: The impacts of synthetic high-density lipoprotein (sHDL) phospholipid components on anti-sepsis effects were investigated. Methods: sHDL composed with ApoA-I mimetic peptide (22A) and different phosphatidylcholines were prepared and characterized. Anti-inflammatory effects were investigated in vitro and in vivo on lipopolysaccharide (LPS)-induced inflammation models. Results: sHDLs composed with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (22A-DMPC) most effectively neutralizes LPS, inhibits toll-like receptor 4 recruitment into lipid rafts, suppresses nuclear factor κB signaling and promotes activating transcription factor 3 activating. The lethal endotoxemia animal model showed the protective effects of 22A-DMPC. Conclusion: Phospholipid components affect the stability and fluidity of nanodiscs, impacting the anti-septic efficacy of sHDLs. 22A-DMPC presents the strongest LPS binding and anti-inflammatory effects in vitro and in vivo, suggesting a potential sepsis treatment.

Idioma original	English
Páginas (desde-hasta)	2127-2142
Número de páginas	16
Publicación	Nanomedicine
Volumen	18
N.º	29
DOI	https://doi.org/10.2217/nnm-2023-0222
Estado	Published - dic 1 2023

Nota bibliográfica

Publisher Copyright:
© 2024 Expert Publishing Medicine Ltd trading as Taylor & Francis.

Financiación

This publication was funded by R01GM113832 (X-A Li and A Schwendeman), VA I01BX004639 (X-A Li) and R01GM121796 (X-A Li) as well as support from American Heart Association 20POST3521818 (L Mei), NIH T32 GM007767 (MV Fawaz), NIH T32 GM008353 (EE Morin), NIH T32 HL125242 (MV Fawaz and EE Morin). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Competing interests disclosure

Financiadores	Número del financiador
National Institutes of Health (NIH)	T32 GM008353, T32 HL125242, T32 GM007767
National Institutes of Health (NIH)
American the American Heart Association	20POST3521818
American the American Heart Association

ASJC Scopus subject areas

Medicine (miscellaneous)
Bioengineering
Biomedical Engineering
General Materials Science
Development

Acceder al documento

10.2217/nnm-2023-0222

Otros archivos y enlaces

Citar esto

@article{9c27017f0d904f80a3e6617b8a9435ab,

title = "Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation",

abstract = "Aim: The impacts of synthetic high-density lipoprotein (sHDL) phospholipid components on anti-sepsis effects were investigated. Methods: sHDL composed with ApoA-I mimetic peptide (22A) and different phosphatidylcholines were prepared and characterized. Anti-inflammatory effects were investigated in vitro and in vivo on lipopolysaccharide (LPS)-induced inflammation models. Results: sHDLs composed with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (22A-DMPC) most effectively neutralizes LPS, inhibits toll-like receptor 4 recruitment into lipid rafts, suppresses nuclear factor κB signaling and promotes activating transcription factor 3 activating. The lethal endotoxemia animal model showed the protective effects of 22A-DMPC. Conclusion: Phospholipid components affect the stability and fluidity of nanodiscs, impacting the anti-septic efficacy of sHDLs. 22A-DMPC presents the strongest LPS binding and anti-inflammatory effects in vitro and in vivo, suggesting a potential sepsis treatment.",

keywords = "endotoxemia, high-density lipoproteins, nanodiscs, phospholipids, sepsis",

author = "Kim, \{Sang Yeop\} and Jukyung Kang and Fawaz, \{Maria V.\} and Minzhi Yu and Ziyun Xia and Morin, \{Emily E.\} and Ling Mei and Karl Olsen and Li, \{Xiang An\} and Anna Schwendeman",

note = "Publisher Copyright: {\textcopyright} 2024 Expert Publishing Medicine Ltd trading as Taylor \& Francis.",

year = "2023",

month = dec,

day = "1",

doi = "10.2217/nnm-2023-0222",

language = "English",

volume = "18",

pages = "2127--2142",

number = "29",

}

TY - JOUR

T1 - Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation

AU - Kim, Sang Yeop

AU - Kang, Jukyung

AU - Fawaz, Maria V.

AU - Yu, Minzhi

AU - Xia, Ziyun

AU - Morin, Emily E.

AU - Mei, Ling

AU - Olsen, Karl

AU - Li, Xiang An

AU - Schwendeman, Anna

PY - 2023/12/1

Y1 - 2023/12/1

N2 - Aim: The impacts of synthetic high-density lipoprotein (sHDL) phospholipid components on anti-sepsis effects were investigated. Methods: sHDL composed with ApoA-I mimetic peptide (22A) and different phosphatidylcholines were prepared and characterized. Anti-inflammatory effects were investigated in vitro and in vivo on lipopolysaccharide (LPS)-induced inflammation models. Results: sHDLs composed with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (22A-DMPC) most effectively neutralizes LPS, inhibits toll-like receptor 4 recruitment into lipid rafts, suppresses nuclear factor κB signaling and promotes activating transcription factor 3 activating. The lethal endotoxemia animal model showed the protective effects of 22A-DMPC. Conclusion: Phospholipid components affect the stability and fluidity of nanodiscs, impacting the anti-septic efficacy of sHDLs. 22A-DMPC presents the strongest LPS binding and anti-inflammatory effects in vitro and in vivo, suggesting a potential sepsis treatment.

AB - Aim: The impacts of synthetic high-density lipoprotein (sHDL) phospholipid components on anti-sepsis effects were investigated. Methods: sHDL composed with ApoA-I mimetic peptide (22A) and different phosphatidylcholines were prepared and characterized. Anti-inflammatory effects were investigated in vitro and in vivo on lipopolysaccharide (LPS)-induced inflammation models. Results: sHDLs composed with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (22A-DMPC) most effectively neutralizes LPS, inhibits toll-like receptor 4 recruitment into lipid rafts, suppresses nuclear factor κB signaling and promotes activating transcription factor 3 activating. The lethal endotoxemia animal model showed the protective effects of 22A-DMPC. Conclusion: Phospholipid components affect the stability and fluidity of nanodiscs, impacting the anti-septic efficacy of sHDLs. 22A-DMPC presents the strongest LPS binding and anti-inflammatory effects in vitro and in vivo, suggesting a potential sepsis treatment.

KW - endotoxemia

KW - high-density lipoproteins

KW - nanodiscs

KW - phospholipids

KW - sepsis

UR - https://www.scopus.com/pages/publications/85182956232

UR - https://www.scopus.com/pages/publications/85182956232#tab=citedBy

U2 - 10.2217/nnm-2023-0222

DO - 10.2217/nnm-2023-0222

M3 - Article

C2 - 38197376

AN - SCOPUS:85182956232

SN - 1743-5889

VL - 18

SP - 2127

EP - 2142

JO - Nanomedicine

JF - Nanomedicine

IS - 29

ER -

Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto